Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VCEL · against 365 other Healthcare companies of similar size
Ranked #40 of 366 · scores higher than 88% of peers
Bars: peers in each 10-point band of the growth score44 peers with a growth score of 90–100, including VCEL · Click a bar to see the companies
Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | VCEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 367 reported | 23.0% | 6.9% | 79% | 33% | |
| Earnings per share growthHigher is better · 206 reported | 235.8% | 9.9% | 94% | 33% | |
| 3-year revenue growthHigher is better · 358 reported | 19.8% | 8.4% | 78% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 40 | 2.21T KRW (≈$1.6B) | 90 | 57 | |
| 40 | 2.29T KRW (≈$1.6B) | 90 | 88 | |
| 40 | 3.8B USD | 90 | 48 | |
| 40 | 1.6B USD | 90 | 43 | |
| 40 | 2.1B USD | 90 | 61 | |
| 45 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 45 | 2.4B EUR (≈$2.6B) | 89 | 69 | |
| 45 | 1.7B USD | 89 | 77 | |
| 45 | 1.8B USD | 89 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score